Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
2C-B Vs. Psilocybin: New Study Shares Insightful Trial Results On The Mescaline-Derived Psychedelic's Effects
February 21, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Tickers
AGNPF
AWKNF
CYBN
DMTTF
Tags
Psychedelics
REUN
CYBN
From
Benzinga
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
February 17, 2023
Tags
Psychedelic/Assisted Therapies
Psychoplastogens
Benzinga
From
Benzinga
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants
February 17, 2023
Tickers
NUMIF
Tags
News
Contract Research Organization
clinical trials
From
Benzinga
Algernon Touts Positive Study Findings, Confirms Next Trial Phase With Escalated Dose
February 16, 2023
Tickers
AGNPF
Tags
Cannabis
Market News
Markets
From
Benzinga
Novel Combination Of Cannabis-Like Compound With Classical Psychedelics Searches IP Coverage In US
February 15, 2023
Tickers
CMND
SPRC
Tags
Contracts
Next/Generation Psychedelics
Global
From
Benzinga
Psychedelics For Alcohol Use Disorder: Awakn Opens European Clinic, FSD Launches R&D Program
February 14, 2023
Tickers
AWKNF
HUGE
Tags
Ketamine Treatment
Benzinga
Psychedelics
From
Benzinga
Psychedelics States Reform: Utah, Iowa and Missouri's New Bills, Hawaii And Arizona's Green Lights, New Hampshire's Setback
February 13, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
Psyched: 12 States Discuss Legalization Bills, Ceremonies For Veterans With TBI, Ketamine And MDMA Fast-Tracks & More
February 13, 2023
Tickers
AWKNF
NUMIF
OPTHF
PHRRF
Tags
Management
Financing
PHRRF
From
Benzinga
Testing Psychedelics Efficacy On 'Psychiatry's Blind Spot': Latest King's College Trial
February 13, 2023
Tags
Psychedelics
Benzinga
Psilocybin program
From
Benzinga
Psychedelic API Market To Reach $6.1B By 2033 Boosted By LSD: New Analysis
February 10, 2023
Tags
Active Pharmaceutical Ingredient
market report
Psychedelics
From
Benzinga
How Do Psilocybin And MDMA Work Together? This Proposed Experiential Study Is Set To Find Out
February 09, 2023
Tickers
OPTHF
Tags
News
Penny Stocks
Market News
From
Benzinga
Psychedelics Legislation: Here's The Latest On Hawaii, Virginia, Missouri And More
February 08, 2023
Tags
Management
Psychedelic/Assisted Therapies
Legal
From
Benzinga
EXCLUSIVE: Social Equity, Adult-Use, Commercialization & Regs For Psychedelics, Lessons From Cannabis
February 08, 2023
Tags
Fox Rothschild
News
Exclusives
From
Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
Tags
NUMIF
News
Psilocybin/Assisted Therapy
From
Benzinga
US Universities Ride The Psychedelics Wave With New Programs In Their Medical Schools
February 06, 2023
Tags
Texas Medical Center
News
Markets
From
Benzinga
EXCLUSIVE: Fox Rothschild Cannabis Attorney Analyzes Psychedelics Regs And Changing Public Perceptions
February 06, 2023
Tickers
CMPS
Tags
Joshua Horn
CMPS
Psychedelic/Assisted Therapies
From
Benzinga
Silo Pharma, Mindset Pharma, Terran Biosciences Receive Psychedelic Treatments Patents, IP Portfolios Expanded
February 03, 2023
Tickers
MSSTF
SILO
Tags
Penny Stocks
USPTO
SILO
From
Benzinga
State-Level Psychedelics Bills: Hawaii And West Virginia, NY And NH Bolster And VA Advances
February 03, 2023
Tags
News
Psychedelics Legalization
Psychedelics
From
Benzinga
'Sea Change': Irwin Naturals, Numinus And Field Trip Discuss Psychedelics At Cantor Webinar
February 03, 2023
Tickers
FTHWF
IWINF
MNMD
NUMIF
Tags
News
Payton Nyquvest
NUMIF
From
Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
Tags
psilocybin therapy
Management
Psychedelic/Assisted Therapies
From
Benzinga
Race Is On For Psychedelic DMT-Related Compounds, Small Pharma, Inc To Issue Two New Patents
February 01, 2023
Tickers
DMTTF
Tags
Benzinga
Psychedelics
DMT Entities
From
Benzinga
This Psychedelic-Assisted Therapy Study Offers Therapists Experience With Magic Mushroom Tea
February 01, 2023
Tickers
NUMIF
Tags
News
Penny Stocks
NUMIF
From
Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead
February 01, 2023
Tickers
CMND
Tags
Dr/ Adi Zuloff/Shani
Markets
CMND
From
Benzinga
Colorado's Psychedelics Bill Advances: Gov. Polis Appoints Natural Medicine Advisory Board
January 31, 2023
Tags
Psychedelics Legalization
News
Colorado
From
Benzinga
Learn How To Safely Facilitate Psychedelic Therapy With These New Training Programs
January 27, 2023
Tags
Therapy Training
News
Psilocybin program
From
Benzinga
Chronic Cluster Headaches, Next Target For This Non-Hallucinogenic Psychedelic
January 27, 2023
Tickers
LOBEF
Tags
Cannabis
Market News
Markets
From
Benzinga
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
January 26, 2023
Tickers
CLABF
Tags
Market News
Cannabis
CLABF
From
Benzinga
BetterLife Engages Canadian Healthcare Investment Firm, Aims For Clinical Trial Programs
January 26, 2023
Tickers
BETRF
Tags
News
Guidance
Penny Stocks
From
Benzinga
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
January 26, 2023
Tickers
DMT
FLHLF
Tags
Psychedelics
Benzinga
Benjamin Lightburn
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.